ベータ
治験レーダーAI

場所 ベルギー に一致する糖尿病の治験(臨床試験)を表示しています。

健康状態や治療法を理解し、近くの治験を探すお手伝いができます。
私たちの検索ツールは英語のみをサポートしています。他の言語で検索と議論するには、上の治験レーダーを使用するか、以下の疾患と場所のフィルターを選択してください。
32 結果
 
疾患名
糖尿病
×
 
キーワード
持続血糖モニタリング
×
 
場所
ベルギー
×
 
性別
全て
×
 
試験の種類
介入研究
×
 
試験タイトル
状況
Continuous Glucose Monitoring for Women with Gestational Diabetes (CORDELIA) NCT06310356
募集中
Beta Cell Function in (Pre)Type 1 Diabetes NCT01402037
状況不明
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period (DETECT) NCT06904846
招待限定
Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes (ALERTT1) NCT03772600
完了
Prospective Randomized Clinical Trial Assessing the Short Term Clinical Impact of Continuous vs Flash Glucose Monitoring in Children, Adolescents and Young Adults With Type 1 Diabetes (GluMoCAY) NCT04249102
状況不明
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes NCT05777330
募集中
The GLOW Study - The YANG System NCT04782934
完了
Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients? NCT00726440
完了
Diabeloop for Kids (DBL4K) NCT03671915
完了
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 1) NCT02268214
完了結果公開
Diabeloop for Teens (DBL4T) NCT04725591
完了
Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes (POC-IDENTITY-1) NCT03414320
完了
Smart MDI Study (CIP343) NCT06645834
完了
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) NCT04880850
完了結果公開
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec (COMBINE 1) NCT05352815
完了結果公開
Hyperglycemia and (Pre)Diabetes in Pediatric Renal and Liver Transplantation. (DIAB-GRAFT) NCT05464043
完了
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) NCT02414958
完了結果公開
Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity (GIIADMT1) NCT04052919
完了
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes (Onset® 5) NCT02825251
完了結果公開
The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects NCT05597605
完了
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® NCT00391027
完了結果公開
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2) NCT02460978
完了結果公開
Single Dose Escalation Study of PF-05190457 in Healthy Volunteers NCT01247896
完了
MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D) (Meld-ATG) NCT04509791
完了
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function NCT04628481
中止
ステージ3の1型糖尿病を有する1歳から25歳の参加者を対象に、Teplizumabの有効性および安全性をプラセボと比較検討する試験 (βETA PRESERVE) NCT07088068
募集中
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes (SAFEGUARD) NCT07187531
募集中
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes NCT01243424
完了結果公開
Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes (DIABIL-2) NCT02411253
完了
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT) NCT03875729
完了結果公開
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) NCT04524949
中止
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (GLUREDIA) NCT06770621
募集中